{
    "id": 24768,
    "fullName": "B2M S14fs",
    "impact": "frameshift",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "B2M S14fs results in a change in the amino acid sequence of the B2m protein beginning at aa 14 of 119, likely resulting in premature truncation of the functional protein (UniProt.org). S14fs confers a loss of function to the B2m protein as demonstrated by lack of MHC class I membrane localization (PMID: 27433843, PMID: 29070816).",
            "references": [
                {
                    "id": 11969,
                    "pubMedId": 29070816,
                    "title": "Resistance to checkpoint blockade therapy through inactivation of antigen presentation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29070816"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 6365,
                    "pubMedId": 27433843,
                    "title": "Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27433843"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 567,
        "geneSymbol": "B2M",
        "terms": [
            "B2M",
            "IMD43"
        ]
    },
    "variant": "S14fs",
    "createDate": "07/25/2016",
    "updateDate": "03/31/2020",
    "referenceTranscriptCoordinates": {
        "id": 91668,
        "transcript": "NM_004048",
        "gDna": "chr15:g.(44711585_44711586)",
        "cDna": "c.(40_39)",
        "protein": "p.S14fs",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7477,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, a melanoma patient treated with Keytruda (pembrolizumab) initially demonstrated a partial response, however, post 453 days, developed disease progression likely due to the secondary resistance mutation, B2M S14fs (PMID: 27433843).",
            "molecularProfile": {
                "id": 25524,
                "profileName": "B2M S14fs"
            },
            "therapy": {
                "id": 1447,
                "therapyName": "Pembrolizumab",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 6365,
                    "pubMedId": 27433843,
                    "title": "Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27433843"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 25524,
            "profileName": "B2M S14fs",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34691,
            "profileName": "B2M S14fs B2M LOH",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 91669,
            "transcript": "XM_005254549",
            "gDna": "chr15:g.(44711585_44711586)",
            "cDna": "c.(40_39)",
            "protein": "p.S14fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 91668,
            "transcript": "NM_004048",
            "gDna": "chr15:g.(44711585_44711586)",
            "cDna": "c.(40_39)",
            "protein": "p.S14fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}